ID
14240
Description
Efficacy of Omalizumab as Add on Therapy for Minority Patients With Moderate to Severe Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT00180011
Link
https://clinicaltrials.gov/show/NCT00180011
Keywords
Versions (1)
- 4/5/16 4/5/16 -
Copyright Holder
CC BY-NC 3.0
Uploaded on
April 5, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Asthma NCT00180011
Eligibility Asthma NCT00180011
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
smoking history
Data type
boolean
Alias
- UMLS CUI [1]
- C1519384
- UMLS CUI [2]
- C3241966
- UMLS CUI [3]
- C1277691
Description
women of childbearing age must be using effective contraception
Data type
boolean
Alias
- UMLS CUI [1]
- C1960468
- UMLS CUI [2]
- C0700589
Description
malignancy
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0006826
- UMLS CUI [1,2]
- C0040223
Description
lung disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0024115
Description
inability to comply with study protocol
Data type
boolean
Alias
- UMLS CUI [1]
- C1321605
Similar models
Eligibility Asthma NCT00180011
- StudyEvent: Eligibility
C0030705 (UMLS CUI [1,2])
C2229760 (UMLS CUI [2])
C0082607 (UMLS CUI [2])
C4039704 (UMLS CUI [3])
C3241966 (UMLS CUI [2])
C1277691 (UMLS CUI [3])
C0700589 (UMLS CUI [2])
C0040223 (UMLS CUI [1,2])